BJMO - volume 13, issue 6, october 2019
C. Debeuckelaere MD, L. Triest MD, T. Vandamme MD, B. Van Den Heuvel MD, K. Papadimitriou MD, M. Rasschaert MD, H. Prenen MD, PhD, M. Peeters MD, PhD
For over a decade, oxaliplatin-based adjuvant chemotherapy has been the gold standard for resected early colon cancer. Oxaliplatin is known to cause polyneuropathy, which affects quality of life dramatically. In recent years, there has not been any progress in the development of novel agents to replace oxaliplatin as adjuvant therapy. Consequently, there is a growing interest to investigate whether a shorter course of chemotherapy is sufficient. This article will discuss the history of adjuvant treatment in early-resected colon cancer, the toxicity of oxaliplatin, the results from the IDEA meta-analysis and future prospects.
(BELG J MED ONCOL 2019;13(6):234–239)
Read moreBJMO - volume 13, issue 6, october 2019
W. Lybaert MD, T. Vandamme MD, G. Boons , K. Vandenborne , L. De Backer , M. Peeters MD, PhD
MARCH 6-8TH, 2019, BARCELONA
Read moreBJMO - volume 12, issue 5, september 2018
W. Lybaert MD, T. Vandamme MD, G. Boons , T. Rondou , M. Twickler , I. Dero MD, F. van Fraeyenhove MD, L. De Backer , D. Van Genechten , M. Peeters MD, PhD
March 7-9, 2018, Barcelona, Spain.
(BELG J MED ONCOL 2018:12(5):252–262)
Read moreBJMO - 12, issue 3, february 2018
T. Vandamme MD, M. Beyens , G. Van Camp , G. Boons , L. Hofland , M. Peeters MD, PhD, K. Op de Beeck
BJMO - 12, issue 3, february 2018
T. Vandamme MD, W. Lybaert MD, M. Simoens , W. Demey MD, T. Rondou , P. Abrams , C. Mattelaer , B. Op De Beeck , O. D’Archambeau , G. Roeyen , L. De Backer , Marc Peeters , Steering Committee , NET-specialists
BJMO - 12, issue 3, february 2018
T. Vandamme MD, I. Maurissen , W. Lybaert MD, M. Simoens , P. Abrams , A. Driessen MD, PhD, B. Op De Beeck , W. Demey MD, T. Rondou , M. Ulenaers , G. Vanhoutte , M. Peeters MD, PhD, Steering Commitee , NET-specialists
BJMO - volume 11, issue 3, may 2017
W. Lybaert MD, M. Simoens , W. Demey MD, F. van Fraeyenhove MD, T. Vandamme MD, L. De Backer , M. Peeters MD, PhD
Barcelona, 8-10 March 2017.
(BELG J MED ONCOL 2017;11(3):129–133)
Read more
Top
